Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $162.60 million. The enterprise value is $202.03 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 132.19 million shares outstanding. The number of shares has increased by 137.61% in one year.
| Current Share Class | 132.19M |
| Shares Outstanding | 132.19M |
| Shares Change (YoY) | +137.61% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 32.92% |
| Float | 130.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,564.61 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11,883.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22
| Current Ratio | 1.22 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -379.75% and return on invested capital (ROIC) is -71.12%.
| Return on Equity (ROE) | -379.75% |
| Return on Assets (ROA) | -59.87% |
| Return on Invested Capital (ROIC) | -71.12% |
| Return on Capital Employed (ROCE) | -248.52% |
| Revenue Per Employee | $159 |
| Profits Per Employee | -$932,402 |
| Employee Count | 107 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.28% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -63.28% |
| 50-Day Moving Average | 1.19 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 44.23 |
| Average Volume (20 Days) | 2,058,685 |
Short Selling Information
The latest short interest is 6.85 million, so 5.18% of the outstanding shares have been sold short.
| Short Interest | 6.85M |
| Short Previous Month | 4.66M |
| Short % of Shares Out | 5.18% |
| Short % of Float | 5.26% |
| Short Ratio (days to cover) | 1.06 |
Income Statement
In the last 12 months, Fractyl Health had revenue of $17,000 and -$99.77 million in losses. Loss per share was -$2.05.
| Revenue | 17,000 |
| Gross Profit | 10,000 |
| Operating Income | -99.84M |
| Pretax Income | -99.77M |
| Net Income | -99.77M |
| EBITDA | -98.85M |
| EBIT | -99.84M |
| Loss Per Share | -$2.05 |
Full Income StatementBalance Sheet
The company has $22.29 million in cash and $61.72 million in debt, giving a net cash position of -$39.43 million or -$0.30 per share.
| Cash & Cash Equivalents | 22.29M |
| Total Debt | 61.72M |
| Net Cash | -39.43M |
| Net Cash Per Share | -$0.30 |
| Equity (Book Value) | -18.21M |
| Book Value Per Share | -0.36 |
| Working Capital | 4.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$81.35 million and capital expenditures -$992,000, giving a free cash flow of -$82.34 million.
| Operating Cash Flow | -81.35M |
| Capital Expenditures | -992,000 |
| Free Cash Flow | -82.34M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
| Gross Margin | 58.82% |
| Operating Margin | -587,305.88% |
| Pretax Margin | -586,864.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -137.61% |
| Shareholder Yield | n/a |
| Earnings Yield | -61.36% |
| FCF Yield | -50.64% |
Analyst Forecast
The average price target for Fractyl Health is $6.90, which is 460.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.90 |
| Price Target Difference | 460.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 287.85% |
| EPS Growth Forecast (5Y) | -13.53% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Fractyl Health has an Altman Z-Score of -14.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.96 |
| Piotroski F-Score | 2 |
